India to Cayman Islands: Nilotinib Export Trade Route

The India to Cayman Islands Nilotinib corridor is one of India's established pharmaceutical export routes, with 1 shipments documented worth a combined $6.5K USD. The route is dominated by VAMA HEALTH WORLD LLP, which alone accounts for roughly 100% of all export value, reflecting the consolidated nature of India's nilotinib manufacturing sector.

Across 1 active suppliers, the average shipment value stands at $6.5K USD — a figure that reflects both bulk commercial orders from large pharmaceutical companies and smaller specialty shipments. Sea freight dominates at 85% of all shipments, consistent with nilotinib's non-urgent bulk-order profile.

Shipment activity peaks during April–June, with an average transit time of 32 days port-to-port. The route has recorded an annual growth rate of 17.9%, placing it at rank #6 among India's top nilotinib export destinations globally.

On the import side, key buyers of Indian nilotinib in Cayman Islands include AS PER INVOICE CAYMAN ISLANDS. AS PER INVOICE CAYMAN ISLANDS is the single largest importer with 1 shipments valued at $6.5K USD.

India's nilotinib exports to Cayman Islands are driven primarily by a handful of large-scale manufacturers. VAMA HEALTH WORLD LLP with 1 shipments leads the pack, a pattern common in generic pharmaceutical corridors where manufacturing scale creates significant cost advantages. The presence of 1 active exporters signals a competitive but concentrated market — buyers in Cayman Islands benefit from supplier diversity while the top tier handles the majority of volume.

The top 3 suppliers — VAMA HEALTH WORLD LLP — together account for 100% of total trade value on this route. The average shipment value of $6.5K USD reflects a mix of bulk commercial orders and smaller specialty shipments.

On the buying side, AS PER INVOICE CAYMAN ISLANDS is the largest importer with 1 shipments worth $6.5K USD — representing 100% of all nilotinib imports from India on this route.